FAQ

Allogeneic Cellular Vaccine 1650-G

Known as: 1650-G, 1650-G Vaccine, 1650G 
A pluripotent, allogeneic, tumor cell vaccine composed of irradiated tumor cells from the non-small cell lung cancer (NSCLC) cell line 1650 and the… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2017
0120002017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
First Report of a Novel Deletion Due to εγδβ-Thalassemia in a Chinese Family.
A fetus of Chinese descent presented with ultrasound features of anemia at 20 weeks' gestation. Father had low a mean corpuscular… (More)
Is this relevant?
2011
2011
Pilot study of 1650-G: a simplified cellular vaccine for lung cancer.
INTRODUCTION Cancer immunotherapy is a conceptually attractive since it is highly specific and can deal with disseminated disease… (More)
Is this relevant?
2005
2005
269 Nasal Continuous Positive Airway Pressure Facilitates Early Neonatal Back Transfer
Introduction: Neonatal networks and dedicated intensive care retrieval systems are evolving in the United Kingdom. Early back… (More)
Is this relevant?
Review
2000
Review
2000
Early versus late discontinuation of oxygen in preterm or low birth weight infants.
BACKGROUND This section is under preparation and will be included in the next issue. OBJECTIVES In preterm or low birth weight… (More)
Is this relevant?